EMERYVILLE, CA — NovaBay Pharmaceuticals Inc., a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, announces the appointments of Justin Hall as president and CEO and Jason Raleigh as chief financial officer.
Hall has served as interim president and CEO, and Raleigh as interim CFO, since March 2019.
“Justin and Jason have proven their leadership abilities by successfully implementing the shift in our U.S. commercial strategy we announced in March and executing the recent launch of our U.S. direct-to-consumer sales of Avenova on Amazon.com,” said Paul E. Freiman, chairman of NovaBay.
“This is a very exciting time at NovaBay as we launch Avenova Direct, making our leading lid and lash spray directly accessible to consumers without a prescription and at affordable pricing,” Hall said. “My close working relationships with our Board, principal investors, and sales force are key to quickly adjusting our strategy to rapidly address opportunities in the marketplace. We are on the move and we have momentum.”
Advertisement
Raleigh said: “I’m honored to be selected as CFO and appreciate the Board’s trust in my abilities. I look forward to continuing to work with Justin and the NovaBay team toward the continued successful commercialization of Avenova.”
Hall has served with NovaBay for six years in a variety of roles, including as corporate counsel, and has been actively involved in a number of operating functions, including the sales organization and manufacturing. Raleigh has been with NovaBay for more than three years and has nearly 20 years of financial experience.
